Dudley Robert Michael → Transcode Therapeutics, Inc. RNAZ

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.36

54,968 shares short · +5.6% vs prior

Other 13D/G Filings on Transcode Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-08-03	SCHEDULE 13D/A	CK Life Sciences Intl (Holdings) Inc	83.90%	14,134,481	view →
2026-07-27	SCHEDULE 13D/A	CK Life Sciences Intl (Holdings) Inc	83.90%	14,134,481	view →
2026-07-23	SCHEDULE 13D/A	CK Life Sciences Intl (Holdings) Inc	—	300,040	view →
2026-07-17	SCHEDULE 13D/A	CK Life Sciences Intl (Holdings) Inc	8.80%	83,285	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →